atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference Post published:March 1, 2023 Post category:Press Release
Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference Post published:March 1, 2023 Post category:Press Release
Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement Post published:March 1, 2023 Post category:Press Release
Algernon Pharmaceuticals Announces 4 for 1 Forward Share Split Post published:March 1, 2023 Post category:Press Release
Enosis Therapeutics announces its response to Australian TGA decision, Plans to Present at SXSW 2023 Post published:February 28, 2023 Post category:Press Release
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights Post published:February 28, 2023 Post category:Press Release
Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023 Post published:February 27, 2023 Post category:Press Release
COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023 Post published:February 24, 2023 Post category:Press Release
Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023 Post published:February 24, 2023 Post category:Press Release
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT Post published:February 24, 2023 Post category:Press Release